In this article you are going to find out whether hedge funds think AzurRx BioPharma, Inc. (NASDAQ:AZRX) is a good investment right now. We like to check what the smart money thinks first before doing ...

If you want to know who really controls AzurRx BioPharma, Inc. (NASDAQ:AZRX), then you’ll have to look at the makeup of its share registry. Generally speaking, as a company grows, institutions will ...

Penny stock AzurRx BioPharma Inc (NASDAQ:AZRX) is higher today, after analysts predicted the stock will more than double. Specifically, Oppenheimer initiated coverage of AZRX with an "outperform" ...

AzurRx has been generating a lot of attention lately. And, while many emerging companies tend to get some early nods from investors and analysts, the focus on AZRX has strong fundamental underpinnings ...

AzurRx BioPharma Inc (NASDAQ:AZRX) is a development stage biopharmaceutical firm whose two pipeline products are being developed to treat exocrine pancreatic insufficiency and c. difficile infections.

AzurRx BioPharma, Inc. AZRX announced positive results from a phase II study evaluating a combination regimen of its lead pipeline candidate, MS1819, as a potential treatment for severe exocrine ...

AzurRx BioPharma, Inc. AZRX announced that it will rename itself as “First Wave BioPharma, Inc.” after the acquisition of a small biotech company, First Wave Bio, Inc. The company acquired First Wave ...

In this article you are going to find out whether hedge funds think AzurRx BioPharma, Inc. (NASDAQ:AZRX) is a good investment right now. We like to check what the smart money thinks first before doing ...

If you want to know who really controls AzurRx BioPharma, Inc. (NASDAQ:AZRX), then you’ll have to look at the makeup of its share registry. Generally speaking, as a company grows, institutions will ...

A look at the shareholders of AzurRx BioPharma, Inc. (NASDAQ:AZRX) can tell us which group is most powerful. Large companies usually have institutions as shareholders, and we usually see insiders ...